Clinical research progress on cervical persistent human papillomavirus infection
10.3760/cma.j.issn.1673-4181.2018.04.014
- VernacularTitle:宫颈人乳头瘤病毒持续性感染的临床研究进展
- Author:
Ning ZHANG
1
;
Xiaomei LIU
Author Information
1. 300193,天津中医药大学研究生院
- Keywords:
Cervical human papillomavirus;
Infection;
Integrative medicine
- From:
International Journal of Biomedical Engineering
2018;41(4):348-353
- CountryChina
- Language:Chinese
-
Abstract:
Cervical cancer is a common malignant tumor of women,which is caused by human papillomavirus(HPV) infection especially high risk HPV infection(HR-HPV).According to the statistics from the World Health Organization (WHO),the incidence and fatality rate of cervical cancers are obviously rising and getting younger in resent years,which seriously threatens the health of women.In China,the mortality of cervical cancer is the first in the female reproductive tract malignant tumor.Although cervical cancer screening has received more and more attention,which reduces the risk of cervical cancer,it does not prevent the necessary factors of cervical cancer,i.e.the HPV infection.Therefore,effective prevention and treatment methods are urgently needed to control the occurrence and development of HPV infection.Both Chinese and Western medicine have made significant progress in the treatment of persistent HPV infection,and they have own advantages and can complement each other.The combination of Chinese and Western medicine is expected to be an effective way to treat cervical persistent HPV infection.
